U.S. markets close in 1 hour 39 minutes

GlaxoSmithKline Consumer Healthcare Limited (GSKCONS.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
10,675.50-57.10 (-0.53%)
At close: 3:30PM IST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in INR

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/16/2021
Current
12/31/2019
Market Cap (intraday) 5
452.25B349.40B
Enterprise Value 3
408.65B305.80B
Trailing P/E
39.0531.76
Forward P/E 1
38.7629.94
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
9.097.10
Price/Book (mrq)
10.858.40
Enterprise Value/Revenue 3
8.2326.39
Enterprise Value/EBITDA 6
23.8978.79

Trading Information

Stock Price History

Beta (5Y Monthly) 0.09
52-Week Change 320.41%
S&P500 52-Week Change 313.47%
52 Week High 311,296.30
52 Week Low 37,201.00
50-Day Moving Average 310,732.60
200-Day Moving Average 310,732.60

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 542.06M
Float 11.5M
% Held by Insiders 172.46%
% Held by Institutions 19.70%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4105
Forward Annual Dividend Yield 40.98%
Trailing Annual Dividend Rate 3105.00
Trailing Annual Dividend Yield 30.98%
5 Year Average Dividend Yield 41.11
Payout Ratio 438.21%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 25, 2019
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Dec 31, 2019

Profitability

Profit Margin 23.19%
Operating Margin (ttm)26.71%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)49.84B
Revenue Per Share (ttm)1,185.13
Quarterly Revenue Growth (yoy)3.80%
Gross Profit (ttm)32.98B
EBITDA 13.89B
Net Income Avi to Common (ttm)11.56B
Diluted EPS (ttm)274.82
Quarterly Earnings Growth (yoy)25.10%

Balance Sheet

Total Cash (mrq)44.16B
Total Cash Per Share (mrq)1,049.86
Total Debt (mrq)556.8M
Total Debt/Equity (mrq)1.34
Current Ratio (mrq)N/A
Book Value Per Share (mrq)989.49

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A